A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes

Diabetes Care

Volumn 31, Issue 2, 2008, Pages 210-215

  Weinzimer, Stuart A ^a   Ternand, Christine ^b   Howard, Campbell ^c   Chang, Cheng Tao ^c   Becker, Dorothy J ^d   Laffel, Lori M B ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Minnesota Physicians   (United States)

^c NOVO NORDISK INC   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN LISPRO;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; ARTICLE; CATHETER COMPLICATION; CHILD; CHILD HEALTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE IRRITATION; INJECTION SITE PRURITUS; INJECTION SITE RASH; INJECTION SITE REACTION; INJECTION SITE SWELLING; INJECTION SITE VESICLE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SEIZURE; SKIN DISEASE; SORE THROAT; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ADOLESCENT; AGE DISTRIBUTION; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; TREATMENT OUTCOME;

EID: 38949149369     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1378     Document Type: Article

References (26)

1. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 22:2643-2653, 2005
2. Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F, European Society for Paediatric Endocrinology, Lawson Wilkins Pediatric Endocrine Society, International Society for Pediatric and Adolescent Diabetes, American Diabetes Association, European Association for the Study of Diabetes: Use of insulinpumptherapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 6:1653-1662, 2007
3. Tamborlane WV, Sikes KA, Steffen AT, Weinzimer SA: Continuous subcutaneous insulin infusion (CSII) in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 74:S112-S115, 2006
4. Ahern JA, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, Tamborlane WV: Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 3:10-15, 2002
5. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP: Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 107:351-356, 2001
6. Plotnick LP, Clark LM, Brancati FL, Erlinger T: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 26:1142-1146, 2003
7. Sulli N, Shashaj B: Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. J Pediatr Endocrinol 16:393-399, 2003
8. Willi SM, Planton J, Egede L, Schwarz S: Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus. J Pediatr 143:796-801, 2003
9. Liberatore R, Perlman K, Buccino J, Artiles-Sisk A, Daneman D: Continuous insulin infusion pump treatment in children with type 1 diabetes mellitus. J Pediatr Endocrinol 17:223-226, 2004
10. Mack-Fogg JE, Orlowski CC, Jospe N: Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes 6:17-21, 2005
11. Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV: Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 114:1601-1605, 2004
12. Hanas R, Adolfsson P: Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes 7:25-31, 2006
13. Physicians' Desk Reference, 61st ed. Florence, KY, Thomson Healthcare, 2006.
14. Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW: Insulin aspart CSII/MDI comparison study group: continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 28:533-538, 2005
15. Tsui E, Barnie A, Ross S, Parkes R, Zinman B: Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 24:1722-1727, 2001
16. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP, Study Group for the Development of Pump Therapy in Diabetes: Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment. Diabetes Care 23:1232-1235, 2000
17. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ, Dutch Insulin Pump Study Group: A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 25:2074-2080, 2002
18. Bode B, Weinstein R, Bell D, McGill J, Nadeau D, Raskin P, Davidson J, Henry R, Huang WC, Reinhardt RR: Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes. Diabetes Care 25:439-444, 2002
19. Bartolo P, Pellicano F, Scaramuzza A, Fabbri T, Melandri P, Miselli V, Casetti T, Cannatà F: Aspart and lispro insulin, is there any difference when used with an insulin pump treatment? Diabetes Res Clin Pract 74:S119-S122, 2006
20. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects [article online], 2004. Available from http://www.wma.net/e/policy/b3.htm. Accessed 7 May 2007
21. International Conference on Harmonization. Guidance for industry: E6 good clinical practice consolidated guidance [article online], 1996. Available from www.fda.gov/cder/guidance/959fnl.pdf. Accessed 7 May 2007
22. Hyperglycemic crises in patients with diabetes mellitus: position statement from the American Diabetes Association. Diabetes Care 25:S100-S108, 2002
23. Standards of medical care in diabetes 2006: position statement from the American Diabetes Association. Diabetes Care 29:S4-S42, 2006
24. National Center for Health Statistics. Z-score data files (ZBMIAGE) http://www.cdc.gov/nchs/about/major/nhanes/growthcharts/zscore/zscore.htm [article online], 2007. Accessed 8 May 2007
25. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV: A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 27:1544-1558, 2004
26. Bode BW, Strange P: Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes. Diabetes Care 24:69-72, 2001